Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: SICAV
  • Objective: European Region
  • Asset Class: Equity
  • Geographic Focus: European Region

Candriam Quant Equities Europe

+ Add to Watchlist

DEXQUAN:LX

2,423.08 EUR 13.33 0.55%

As of 00:59:30 ET on 03/31/2015.

Snapshot for Candriam Quant Equities Europe (DEXQUAN)

Year To Date: +17.60% 3-Month: +18.08% 3-Year: +16.31% 52-Week Range: 1,867.71 - 2,451.23
1-Month: +2.20% 1-Year: +20.05% 5-Year: +9.66% Beta vs MXEU: 0.98

Mutual Fund Chart for DEXQUAN

No chart data available.
  • DEXQUAN:LX 2,423.08
  • 1M
  • 1Y
Interactive DEXQUAN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DEXQUAN

Candriam Quant - Equities Europe is a SICAV incorporated under the laws of Luxembourg. The Fund's objective is capital appreciation. The Fund invests at least two-thirds of its assets in European equities. The Fund may also invest in warrants, liquidities and money-market instruments.

Inception Date: 03-26-2003 Telephone: 352-254-3431
Managers: BART GOOSENS / ERWIN DE WINTER
Web Site: www.candriam.com

Fundamentals for DEXQUAN

NAV (on 2015-03-31) 2,423.08
Assets (M) (on 2015-03-30) 993.85
Fund Leveraged N
Minimum Investment 0.00
Minimum Subsequent Investment -

Dividends for DEXQUAN

No dividends reported

Fees & Expenses for DEXQUAN

Front Load 3.50
Back Load 0.00
Current Mgmt Fee 1.50
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.76

Top Fund Holdings for DEXQUAN

Filing Date: 02/27/2015
Name Position Value % of Total
Nestle SA 436,287 30,526,666 3.132%
Novartis AG 333,034 30,521,410 3.132%
Roche Holding AG 124,043 30,190,528 3.098%
Novo Nordisk A/S 453,521 19,429,770 1.994%
British American Tobacco PLC 339,702 17,701,224 1.816%
Unilever NV 441,463 17,172,911 1.762%
Imperial Tobacco Group PLC 372,084 16,369,054 1.680%
HSBC Holdings PLC 2,052,630 16,326,605 1.675%
Bayer AG 118,374 15,631,287 1.604%
Royal Dutch Shell PLC 533,163 15,600,349 1.601%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil